Clinical Trial Update: Utility Study of Primovist-MRI on HCC Staging

View source ↗

Summary

This clinical trial update assesses the utility of Primovist-MRI for staging hepatocellular carcinoma. The study is sponsored by Inha University Hospital.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Primovist (Gadoxetate disodium)

Snippet

Sponsor: Inha University Hospital | Conditions: Hepatocellular Carcinoma | Status: UNKNOWN